Gilead Sciences
- C01 - Terapia cardíaca
- RANEXA prolonged-release tablet 1 000 mg
- RANEXA prolonged-release tablet 500 mg
- C02 - Antihipertensivos
- LETAIRIS film-coated tablet 10 mg
- LETAIRIS film-coated tablet 5 mg
- J01 - Antibacterianos para uso sistémico
- CAYSTON inhalation powder 75 mg
- J05 - Antivirales de uso sistémico
- BIKTARVY film-coated tablet 200 mg+25 mg+50 mg
- COMPLERA film-coated tablet 200 mg+245 mg+25 mg
- DESCOVY film-coated tablet 200 mg+25 mg
- EMTRIVA capsule, hard 200 mg
- EMTRIVA oral solution 10 mg/ml
- GENVOYA film-coated tablet 150 mg+150 mg+200 mg+10 mg
- HEPSERA tablet 10 mg
- ODEFSEY film-coated tablet 200 mg+25 mg+25 mg
- SOVALDI film-coated tablet 400 mg
- STRIBILD film-coated tablet 200 mg+300 mg+150 mg+150 mg
- TRUVADA film-coated tablet 245 mg+200 mg
- VEMLIDY film-coated tablet 25 mg
- VIREAD ACCESS film-coated tablet 245 mg
- VIREAD film-coated tablet 123 mg
- VIREAD film-coated tablet 163 mg
- VIREAD film-coated tablet 204 mg
- VIREAD film-coated tablet 245 mg
- VIREAD oral powder 33 mg/g
- VISTIDE concentrate for solution for infusion 375 mg/5 ml
- VITEKTA film-coated tablet 150 mg
- VITEKTA film-coated tablet 85 mg
- L01 - Antineoplásicos
- DAUNOXOME concentrate for solution for infusion 50 mg/25 ml